Systematic review-Time to malignant transformation in low-grade gliomas: Predicting a catastrophic event with clinical, neuroimaging, and molecular markers.

Satar, Zabina; Hotton, Gary; Samandouras, George

Satar, Zabina; Hotton, Gary; Samandouras, George.

Afiliação

Satar Z; University College London, Queen Square Institute of Neurology, London, UK.
Hotton G; University College London Hospitals NHS Trust, Victor Horsley Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, UK.
Samandouras G; The National Hospital for Neurology and Neurosurgery, Queen Square, UK.

Neurooncol Adv ; 3(1): vdab101, 2021.

Article em En | MEDLINE | ID: mdl-34466805

Palavras-chave

clinical marker; low-grade glioma; malignant transformation; molecular marker; radiological marker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Neurooncol Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google